In this episode of the Good Value podcast, Alison Savas interviews James Rodda, Lead Portfolio Manager of the Antipodes Global SMIDs Fund, to explore why global small and mid-cap stocks (SMIDs) present powerful, under-appreciated alpha opportunities.
They unpack the valuation gap between SMIDs and large caps, and how Antipodes’ strong investment platform and industry-led research approach provides a unique edge in identifying mis-priced opportunities.
Key times:
Why Antipodes launched a global SMID Fund (Antipodes Global Opportunities Fund): 0:45
Why investors should consider an allocation to global SMIDs: 3:00
The importance of industry-led research & discussion about investing in Roku Inc (NASDAQ: ROKU): 08:00
Antipodes gobal SMID Fund performance: 18:00
Why Brookdale Senior Living Inc (NYSE: BKD) is one of the Fund’s largest positions: 24:50
Stock commentary is illustrative only, not a recommendation to buy, hold, or sell any security.
You can subscribe to our podcast on Apple or Spotify, to be notified as soon as upcoming episodes are published
Subscribe to receive the latest news and insights from the Antipodes team


